튼살 치료 시장 규모, 점유율, 동향, 예측 : 치료별, 유통 채널별, 최종사용자별, 지역별(2025-2033년)

The global stretch marks treatment market size was valued at USD 3.13 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.95 Billion by 2033, exhibiting a CAGR of 5.2% from 2025-2033.Key stretch marks treatment market trends in North America include the high demand for advanced skincare solutions due to increased awareness, rising disposable income, and the prevalence of post-pregnancy and weight-related skin concerns. As per the WHO article released in August 2024, roughly 1 in 8 people worldwide experienced obesity in 2022.

Stretch marks are scars or irregular lines that develop when the skin stretches or shrinks suddenly. They are widely caused by unexpected changes in the body that cause the collagen and elastin to rupture and as the skin heals naturally, stretch marks occur. They are also caused by Cushing syndrome, abnormal collagen formation and Ehlers-danlos syndrome. Stretch marks are common in pregnant women and individuals with rapid changes in muscle size due to significant weight gain or weight loss. Some of the commonly used stretch mark treatment solutions include lotions, creams, pulse-dye lasers, fractional lasers, oil and serums. They aid in reducing the visibility of stretch marks by rebuilding collagen for tightening the skin and treating open pores and fine lines.

Stretch Marks Treatment Market Trends:

The increasing incidence of obesity among the masses is one of the key factors driving the market growth. With the changing dietary patterns and the rising adoption of sedentary lifestyles, individuals are widely suffering from excessive weight gain, which is leading to the development of stretch marks. Moreover, the increasing product demand among pregnant women is favoring the market growth. Stretch marks lotions, oils and serums are fortified with essential oils and nutrients that aid in minimizing the visibility of stretched and broken skin and promote healing. Additionally, various product innovations, such as the launch of chemical peels, platelet-rich plasma (PRP), micro-needling, non-invasive microdermabrasion and laser-based treatment procedures, are providing a thrust to the market growth. These procedures aid in the breakdown of old collagen and promote the development of new skin tissues. Other factors, including the convenient availability of over-the-counter stretch marks ointments, along with the increasing consciousness among the masses regarding their physical appearance, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Treatment:

• Topical Products
• Creams
• Oils and Serum
• Lotions
• Lasers
• Fractional Lasers
• Pulse-Dye Lasers
• Others
• Microdermabrasion
• Others

Breakup by Distribution Channel:

• Institutional
• Retail
• Supermarkets and Hypermarkets
• Specialist Retailers
• Medical Retailers
• Online Stores
• Others

Breakup by End User:

• Hospitals and Clinics
• Home Use
• Specialty Dermatology Centers
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alliance Pharma PLC, basq NYC, Bayer AG, Candela Corporation, Clarins, Dermaclara, E.T. Browne Drug Co. Inc., Helix Biomedix Inc., HRA Pharma (Perrigo Company plc), Laboratoires Expanscience, Union-Swiss (Pty) Ltd and Weleda.

Key Questions Answered in This Report

• 1.What is a stretch mark?
• 2.How big is the stretch marks treatment market?
• 3.What is the expected growth rate of the global stretch marks treatment market during 2025-2033?
• 4.What are the key factors driving the global stretch marks treatment market?
• 5.What is the leading segment of the global stretch marks treatment market based on treatment?
• 6.What is the leading segment of the global stretch marks treatment market based on end user?
• 7.What are the key regions in the global stretch marks treatment market?
• 8.Who are the key players/companies in the global stretch marks treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Stretch Marks Treatment Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Treatment

• 6.1 Topical Products
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Creams
    • 6.1.2.2 Oils and Serum
    • 6.1.2.3 Lotions
  • 6.1.3 Market Forecast
• 6.2 Lasers
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Fractional Lasers
    • 6.2.2.2 Pulse-Dye Lasers
    • 6.2.2.3 Others
  • 6.2.3 Market Forecast
• 6.3 Microdermabrasion
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

• 7.1 Institutional
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Retail
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Supermarkets and Hypermarkets
    • 7.2.2.2 Specialist Retailers
    • 7.2.2.3 Medical Retailers
    • 7.2.2.4 Online Stores
    • 7.2.2.5 Others
  • 7.2.3 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Home Use
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Specialty Dermatology Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Alliance Pharma PLC
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 basq NYC
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Bayer AG
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Candela Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Clarins
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Dermaclara
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 E.T. Browne Drug Co. Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Helix Biomedix Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 HRA Pharma (Perrigo Company plc)
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Laboratoires Expanscience
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Union-Swiss (Pty) Ltd
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Weleda
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio